Healthcare & clinical workflows
Intake, vision quality gates, care discovery - cases: AI Dent, Heva.
Enterprise References
Named references only with written customer approval. Until then: published case methodology plus anonymized industry-scale references under NDA, never fabricated logos or Fortune 500 claims.
Perspective
Enterprise buyers should verify delivery risk the same way they verify architecture: with peers and evidence, not marketing claims. InheritX supports three tiers of proof.
We will not invent customer names, awards, or partnership badges to close a diligence gap. If a named reference is not approved, we say so and offer an approved alternative path.
How we engage
01
Methodology-forward stories on this site, challenge, approach, outcome, and measurable results where we can publish them.
02
Industry, size band, use case, constraint, InheritX role, and outcome class, shared after mutual fit is confirmed.
03
Only with written customer approval. Requested for qualified opportunities; scheduling depends on customer availability.
Capabilities
Available now from published case studies, not invented client names. Prefer these for early peer matching before NDA.
Intake, vision quality gates, care discovery - cases: AI Dent, Heva.
AI builder infrastructure and recovery - case: Kavia AI.
Posture hardening for AI platforms - case: T2D2.
Multi-property and real-time operations - cases: QDIS, Twelfthman, E-mobility.
Capabilities
Industry, geography, and approximate scale so we match the closest approved reference, not a vanity logo.
Whether you need architecture review, security questionnaire support, or a customer call.
If your process requires NDA before references or pack materials, say so early.
Next step
A focused strategy conversation, constraints, systems, and what production readiness looks like for your organization.